2024 21st Annual Indy Hematology Review

This full, one-day, comprehensive regional educational hematology symposium will be held February 24, 2024 at Westin Indianapolis, Indianapolis IN from 7:30 a.m. to 8:30 p.m. The live symposium will feature 30+ presentations throughout the day as part of two concurrent morning break-out sessions - (1) Session A - Symposium for Doctors and Other Healthcare Professionals and Session B - Nursing and Allied Providers Symposium, (2) afternoon session for all participants (including Q&A and Discussion sessions), and (3) separate Town Hall session held early evening. Hematology and oncology experts provide clinicians with the tools and information needed to interpret clinical trial data regarding therapeutic agents, including novel combinations and their potential place in therapy, and up-to-date clinical, experimental, safety information on emerging hematology treatment approaches and the application of clinical data in minority populations with key emphasis on diversity, inclusion and equity.  Topics include various leukemias and lymphomas (including Hodgkin and non-Hodgkin), amyloidosis, aplastic anemia, benign hematology, disorders (bleeding and clotting, indolent plasma cell, myeloproliferative), lymphoid malignancies, multiple myeloma, myelodysplastic syndromes, paroxysmal Nocturnal hemoglobinuria, sickle cell disease, Waldenström's Macroglobulinemia, hematopoietic stem cell transplantation and cellular therapies.  This annual event is one of the most comprehensive, educational hematology conferences in the country.

This live event has a regional scope, with participants primarily from the Midwest states (Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin).  It is planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center’s Commission on Accreditation (ANCC).  Purdue University College of Pharmacy Office of Continuing Education and Professional Development (Purdue) is an approved accredited provider for Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians and Accreditation Council for Pharmacy Education (ACPE) for pharmacist continuing education, and the Purdue University School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) to provide CE contact hours for nurses.  Purdue will designate the full-day symposium for a maximum of 9.75 AMA PRA Category 1 Credit(s)™, ACPE, and ANCC and the separate evening Town Hall for a maximum of 1.0 AMA PRA Category 1 Credit(s)™, ACPE, and ANCC.   Additionally, ABIM Maintenance of Certification (MOC) Part 2 credit will be provided to physicians for a maximum of 9.75 MOC points for the full-day symposium and a maximum of 1.0 MOC points for the separate evening Town Hall session.  Successful completion of this CME event and post-event online evaluation component enables the participant to earn the CE credit. Purdue will submit participant completion information (e.g., CPE Monitor) and issue certificates of completion as requested. Participants should claim only the credit commensurate with the extent of their participation. 

Information (e.g., registration and program-specific) regarding this one-day, live event is located at https://www.indyhematologyreview.com/